anmelden
25 € WM-Startbonus auf dein Cash-Konto
BX Swiss TOP 30 CHF
1.480,29
PKT
-6,17
PKT
-0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.01.12 | Kühne + Nagel International buy | Citigroup Corp. | |
| 24.01.12 | Roche buy | Deutsche Bank AG | |
| 24.01.12 | Novartis buy | Sarasin Research | |
| 24.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.01.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 23.01.12 | Roche overweight | Barclays Capital | |
| 23.01.12 | Novartis buy | Nomura | |
| 20.01.12 | Givaudan reduce | Nomura | |
| 20.01.12 | Novartis buy | Nomura | |
| 20.01.12 | Swiss Re neutral | Nomura | |
| 20.01.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
| 19.01.12 | Roche overweight | Barclays Capital | |
| 20.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
| 19.01.12 | Holcim hold | Deutsche Bank AG | |
| 19.01.12 | Swiss Re buy | Sarasin Research | |
| 19.01.12 | ABB (Asea Brown Boveri) verkaufen | National-Bank AG | |
| 19.01.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 19.01.12 | UBS overweight | Morgan Stanley | |
| 18.01.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 18.01.12 | UBS underperform | Exane-BNP Paribas SA | |
| 18.01.12 | UBS underperform | Exane-BNP Paribas SA | |
| 18.01.12 | Novartis halten | Independent Research GmbH | |
| 18.01.12 | Novartis hold | Vontobel Research | |
| 17.01.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.01.12 | Nestlé buy | UBS AG | |
| 17.01.12 | Holcim neutral | Sarasin Research | |
| 17.01.12 | Novartis buy | Nomura | |
| 17.01.12 | ABB (Asea Brown Boveri) outperform | Credit Suisse Group | |
| 16.01.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | Nestlé buy | UBS AG | |
| 16.01.12 | Partners Group overweight | Morgan Stanley | |
| 16.01.12 | Nestlé hold | Vontobel Research | |
| 16.01.12 | Lindt hold | Vontobel Research | |
| 16.01.12 | Holcim hold | Vontobel Research | |
| 16.01.12 | Novartis buy | WestLB AG | |
| 16.01.12 | Zurich Insurance buy | Citigroup Corp. | |
| 16.01.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 16.01.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 13.01.12 | UBS neutral | UBS AG |